Argiris A - Search Results

1

XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.

Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, Weaver DT, D'Andrea AD, Argiris A, Romkes M, Niedernhofer LJ, Grandis JR. Vaezi A, et al. Among authors: argiris a. Clin Cancer Res. 2011 Aug 15;17(16):5513-22. doi: 10.1158/1078-0432.CCR-11-0086. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737503 Free PMC article.

2

Splenic and renal infarctions complicating atrial fibrillation.

Argiris A. Argiris A. Mt Sinai J Med. 1997 Sep-Oct;64(4-5):342-9. Mt Sinai J Med. 1997. PMID: 9293737

3

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.

Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ, Vokes EE. Argiris A, et al. Ann Oncol. 2003 Aug;14(8):1306-11. doi: 10.1093/annonc/mdg330. Ann Oncol. 2003. PMID: 12881397 Free article.

4

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE. Haraf DJ, et al. Among authors: argiris a. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5936-43. Clin Cancer Res. 2003. PMID: 14676118

5

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.

Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Argiris A, et al. J Clin Oncol. 2004 Jan 15;22(2):262-8. doi: 10.1200/JCO.2004.08.039. J Clin Oncol. 2004. PMID: 14722034 Clinical Trial.

6

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.

Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Jovanovic B, Vokes EE. Argiris A, et al. Clin Cancer Res. 2004 Mar 15;10(6):1956-62. doi: 10.1158/1078-0432.ccr-03-1077. Clin Cancer Res. 2004. PMID: 15041712

7

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE. Milano MT, et al. Among authors: argiris a. Clin Cancer Res. 2004 Aug 1;10(15):4922-32. doi: 10.1158/1078-0432.CCR-03-0634. Clin Cancer Res. 2004. PMID: 15297392 Clinical Trial.

8

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.

Argiris A, Li Y, Forastiere A. Argiris A, et al. Cancer. 2004 Nov 15;101(10):2222-9. doi: 10.1002/cncr.20640. Cancer. 2004. PMID: 15452834 Free article.

9

Induction chemotherapy for head and neck cancer: will history repeat itself?

Argiris A. Argiris A. J Natl Compr Canc Netw. 2005 May;3(3):393-403. doi: 10.6004/jnccn.2005.0020. J Natl Compr Canc Netw. 2005. PMID: 16002005 Review.

10

Planned post-chemoradiation neck dissection: significance of radiation dose.

Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE. Stenson KM, et al. Among authors: argiris a. Laryngoscope. 2006 Jan;116(1):33-6. doi: 10.1097/01.mlg.0000185846.27617.fe. Laryngoscope. 2006. PMID: 16481805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters